PH16620A - Combination of thienamycin-type antibiotics with dipeptidase inhibitors - Google Patents

Combination of thienamycin-type antibiotics with dipeptidase inhibitors

Info

Publication number
PH16620A
PH16620A PH22771A PH22771A PH16620A PH 16620 A PH16620 A PH 16620A PH 22771 A PH22771 A PH 22771A PH 22771 A PH22771 A PH 22771A PH 16620 A PH16620 A PH 16620A
Authority
PH
Philippines
Prior art keywords
thienamycin
combination
type antibiotics
dipeptidase inhibitors
dipeptidase
Prior art date
Application number
PH22771A
Other languages
English (en)
Inventor
Frederick M Kahan
Helmut Kropp
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26728043&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PH16620(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of PH16620A publication Critical patent/PH16620A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/3804—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
    • C07F9/3808—Acyclic saturated acids which can have further substituents on alkyl

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
PH22771A 1978-07-24 1979-07-12 Combination of thienamycin-type antibiotics with dipeptidase inhibitors PH16620A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US92721378A 1978-07-24 1978-07-24
US5023279A 1979-06-22 1979-06-22

Publications (1)

Publication Number Publication Date
PH16620A true PH16620A (en) 1983-11-28

Family

ID=26728043

Family Applications (1)

Application Number Title Priority Date Filing Date
PH22771A PH16620A (en) 1978-07-24 1979-07-12 Combination of thienamycin-type antibiotics with dipeptidase inhibitors

Country Status (19)

Country Link
EP (1) EP0007614B1 (cs)
AR (1) AR244550A1 (cs)
AU (1) AU529315B2 (cs)
CA (1) CA1136549A (cs)
CZ (1) CZ280583B6 (cs)
DD (1) DD145059A5 (cs)
DE (1) DE2964609D1 (cs)
EG (1) EG14367A (cs)
ES (1) ES482774A1 (cs)
FI (1) FI792282A7 (cs)
GR (1) GR69997B (cs)
HK (1) HK23286A (cs)
HU (1) HU182973B (cs)
IE (1) IE51691B1 (cs)
IL (1) IL57798A (cs)
NZ (1) NZ190993A (cs)
PH (1) PH16620A (cs)
PT (1) PT69955B (cs)
SK (1) SK513779A3 (cs)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4880793A (en) * 1978-07-24 1989-11-14 Merck & Co., Inc. Combination of thienamycin-type antibiotics with dipeptidase inhibitors
US5071843A (en) * 1978-07-24 1991-12-10 Merck & Co., Inc. Combination of 2-substituted carbapenems with dipeptidase inhibitors
GR70784B (cs) * 1979-11-02 1983-03-23 Merck & Co Inc
DE48025T1 (de) * 1980-09-17 1983-03-17 Merck & Co., Inc., 07065 Rahway, N.J. Z-omega-(substituierte) 2-(cyclopropan-carboxamido)-2-alkensaeuren, deren ester und salze und diese enthaltende antibakterielle zusammensetzungen und eine verbindung der thienamycin-gattung.
PT73640B (en) * 1980-09-17 1983-10-19 Merck & Co Inc Process for preparing chemical compounds selectively inhibit the metabolism of dipeptidase
DE48301T1 (de) * 1980-09-24 1983-01-20 Merck & Co., Inc., 07065 Rahway, N.J. 2-(cyclopropancarboxamido)-2-alkensaeuren, deren ester und salze und daraus bestehende bakterienhemmende zusammensetzungen mit einer verbindung des typs thienamycin.
NZ201471A (en) * 1981-08-10 1985-09-13 Merck & Co Inc Antibacterial compositions containing penems and dipeptidase inhibitors
JPS6025952A (ja) * 1983-07-20 1985-02-08 Sumitomo Chem Co Ltd 光学活性２，２−ジメチルシクロプロパン−１−カルボン酸誘導体の製造法
EP0161546B1 (en) * 1984-04-30 1989-12-13 Merck & Co. Inc. Combination of 2-substituted carbapenems with dipeptidase inhibitors
CA1273012A (en) * 1984-07-02 1990-08-21 Burton G. Christensen 1-methylcarbapenems having an externally alkylated mono- of bicyclic 2-quarternary heteroarylalkylthio substituent
IE851586L (en) * 1984-07-02 1986-01-02 Interchem Internat S A I methylcarbapenems having a 2-quaternary¹heteroarylalkylthio substituent
CA1273011A (en) * 1984-07-02 1990-08-21 Susan M. Schmitt Carbapenems having an externally alkylated mono- or bicyclic 2-quaternary heteroarylalkylthio substituent
NO172099C (no) * 1984-10-15 1993-06-09 Sankyo Co Fremgangsmaate til fremstilling av et preparat som inneholder et penem -eller karbapenemantibiotikum og en n-acetylert aminosyre
US4680292A (en) * 1984-12-13 1987-07-14 Merck & Co., Inc. Carbapenems and 1-methylcarbapenems having a 2-heteroaryliumaliphatic substituent
US4739113A (en) * 1986-05-30 1988-04-19 Merck & Co., Inc. Bis(cyclopropanecarboxamido)alkadienedioic acids as renal dipeptidase inhibitors
EP0464900A3 (en) 1990-06-26 1992-07-22 Merck & Co. Inc. 2-biphenyl-carbapenems
CA2052730A1 (en) 1990-10-11 1992-04-12 Frank P. Dininno 2-(substituted-dibenzofuranyl and dibenzothienyl) carbapenem antibacterial agents
DE69232598T2 (de) * 1991-02-01 2002-11-21 Suntory Limited, Osaka Verwendung von Cilastatin, Glutathione und N-acetyl-L-Cysteine zur Herstellung eines Arzneimittels zur Verbesserung der Resorption von Carbapenem oder Penem Antibiotika im Magen-Darm-Trakt
US6297231B1 (en) 1996-10-28 2001-10-02 Merck & Co., Inc. Stabilized carbapenem antibiotic compositions and method of making
US6255300B1 (en) 1997-09-09 2001-07-03 Merck & Co., Inc. Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment
US6277843B1 (en) 1997-09-17 2001-08-21 Merck & Co., Inc. Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment
US6271222B1 (en) 1998-05-28 2001-08-07 Merck & Co., Inc. Penem antibacterial compounds, compositions and methods of treatment
US6288054B1 (en) 1998-06-02 2001-09-11 Merck & Co., Inc. Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment
US6284753B2 (en) 1998-06-02 2001-09-04 Merck & Co., Inc. Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment
US6310055B2 (en) 1998-06-02 2001-10-30 Merck & Co., Inc. Halophenoxy substituted carbapenem antibacterial compounds
US6265395B1 (en) 1998-06-25 2001-07-24 Merck & Co., Inc. Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment
WO1999067240A1 (en) 1998-06-25 1999-12-29 Merck & Co., Inc. (heterocyclic)methyl substituted carbapenem antibacterials
WO1999067241A1 (en) 1998-06-25 1999-12-29 Merck & Co., Inc. (heterocyclic) methyl substituted carbapenem antibacterials
JP2002518447A (ja) 1998-06-25 2002-06-25 メルク エンド カムパニー インコーポレーテッド カルバペネム抗菌性化合物、前記化合物を含む組成物及び治療方法
US6346526B1 (en) 1998-06-25 2002-02-12 Merck & Co., Inc. Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment
US6316488B1 (en) 1999-06-17 2001-11-13 Merck & Co., Inc. Antibiotic compound
US6221859B1 (en) 1999-08-27 2001-04-24 Merck & Co., Inc. Carbapenem antibacterial compositions and methods of the treatment
WO2012104793A1 (en) * 2011-02-02 2012-08-09 Indian Council Of Medical Research An antibacterial and antiviral compound
US20140243302A1 (en) 2011-06-27 2014-08-28 Merck Sharp & Dohme Corporation Bridged bicyclic compounds for the treatment of bacterial infections

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2272684A1 (en) * 1975-01-07 1975-12-26 Ito Shojiro Antibiotic-unsaturated acid compsns. - having a synergistic effect against gram positive and negative bacteria

Also Published As

Publication number Publication date
HU182973B (en) 1984-03-28
PT69955B (pt) 1981-06-11
IL57798A0 (en) 1979-11-30
CZ513779A3 (en) 1995-10-18
DE2964609D1 (en) 1983-03-03
EP0007614B1 (en) 1983-01-26
PT69955A (en) 1979-08-01
ES482774A1 (es) 1980-09-01
AU4893279A (en) 1980-01-31
SK278357B6 (en) 1997-01-08
IE51691B1 (en) 1987-02-18
CZ280583B6 (cs) 1996-02-14
IE791388L (en) 1980-01-24
SK513779A3 (en) 1997-01-08
GR69997B (cs) 1982-07-23
AU529315B2 (en) 1983-06-02
CA1136549A (en) 1982-11-30
AR244550A1 (es) 1993-11-30
IL57798A (en) 1986-11-30
DD145059A5 (de) 1980-11-19
HK23286A (en) 1986-04-11
NZ190993A (en) 1981-10-19
FI792282A7 (fi) 1981-01-01
EP0007614A1 (en) 1980-02-06
EG14367A (en) 1984-09-30

Similar Documents

Publication Publication Date Title
PH16620A (en) Combination of thienamycin-type antibiotics with dipeptidase inhibitors
PH16961A (en) Cephalosporin antibiotics
AU521129B2 (en) Determination of ammonia
AU529682B2 (en) N-acylated derivatives of aminoglyosidic antibiotics
GB2058791B (en) Cephalosporin antibiotics
PH15928A (en) Cephalosporin antibiotics (ce259)
IL55431A0 (en) Novel derivatives of antibiotics
NZ192127A (en) Cephalosporin antibiotics
PT69535A (en) Process for the preparation of beta-lactam antibiotics
NZ187461A (en) Penicillins and cephalosporins
ZA796195B (en) Cephalosporin antibiotics
GB2021582B (en) Antibiotics
GB2040921B (en) Cephalosporin antibiotics
ZA796130B (en) Cephalosporin antibiotics
ZA792582B (en) Cephalosporin antibiotics
ZA793745B (en) Combination of thienamycin-type antibiotics with dipeptide inhibitors
GB2027691B (en) Cephalosporin antibiotics
GB2036738B (en) Cephalosporin antibiotics
DE3169567D1 (en) The preparation of beta-lactam antibiotics
GB2027692B (en) Cephalosporin antibiotics
ZA792584B (en) Cephalosporin antibiotics
GB2024808B (en) Cephalosporin antibiotics
JPS52117490A (en) Droduction of zalcocine dihydrogenase enzyme
JPS5321155A (en) Preparation of antibiotics
JPS5589671A (en) Freezing chamber